Compositions for pre-surgical nutritional supplements
US-2024189256-A1 · Jun 13, 2024 · US
US2020323899A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2020323899-A1 |
| Application number | US-202016915559-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jun 29, 2020 |
| Priority date | Jun 17, 2013 |
| Publication date | Oct 15, 2020 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Polypeptides having the ability to specifically form connections of glucosyl units in alpha 1,3 on an acceptor having at least one hydroxyl moiety are presented. The polypeptides include i) the pattern I of sequence SEQ ID NO: 1, ii) the pattern II of sequence SEQ ID NO: 2, iii) the pattern III of sequence SEQ ID NO: 3, and iv) the pattern IV of sequence SEQ ID NO: 4, or derivates from one or several of said patterns, wherein the polypeptide furthermore has an aspartic residue (D) at position 5 of the pattern II (SEQ ID NO: 2), a glutamic acid residue (E) at position 6 of the pattern III (SEQ ID NO: 3) an an aspartic acid residue (D) at position 6 of the pattern IV (SEQ ID NO: 4). Methods for producing acceptors connected to glucosyl units in alpha 1,3 using the polypeptides are also provided.
Opening claim text (preview).
1 . A recombinant polypeptide comprising an amino acid sequence that is at least 99 percent identical to SEQ ID NO: 12, and wherein said polypeptide maintains an aspartic acid residue (D) at position 5 of the pattern II (SEQ ID NO: 2), a glutamic acid residue (E) at position 6 of the pattern III (SEQ ID NO: 3), and an aspartic acid residue (D) at position 6 of the pattern IV (SEQ ID NO: 4). 2 . An expression vector comprising a nucleic acid encoding the recombinant polypeptide of claim 1 . 3 . A host cell comprising the vector of claim 2 . 4 . A composition comprising the recombinant polypeptide of claim 1 . 5 . A composition comprising the expression vector of claim 2 . 6 . A composition comprising the host cell of claim 3 . 7 . A method of producing a recombinant polypeptide from a cell, said method comprising culturing the host cell of claim 3 so that the polynucleotide encoding the recombinant polypeptide is expressed and the recombinant polypeptide is secreted. 8 . A method for producing acceptors connected to glucosyl units in alpha 1,3 comprising a rate of connections of such glucosyl units in alpha 1,3 between 1 and 50%, said method comprising the steps of: (i) mixing in a reaction medium: an isolated polypeptide having the ability to specifically form connections of glucosyl units in alpha-1,3 on an acceptor having at least one hydroxyl moiety, said polypeptide having a sequence identity of at least 99% with SEQ ID NO: 12, and wherein said polypeptide maintains an aspartic acid residue (D) at position 5 of the pattern II (SEQ ID NO: 2), a glutamic acid residue (E) at position 6 of the pattern III (SEQ ID NO: 3), and an aspartic acid residue (D) at position 6 of the pattern IV (SEQ ID NO: 4); a substrate of said polypeptide and; an acceptor comprising at least one hydroxyl moiety; and (ii) incubating said mixture obtained in step (i) so as to obtain connection of glucosyl units in alpha-1,3 on said acceptor, wherein the rate of connections of such glucosyl units in alpha 1,3 is controlled by varying the ratio between the substrate concentration and the acceptor concentration. 9 . The method of claim 6 , wherein the substrate is selected from the group consisting of α-D-glucopyranosyl fluoride, p-nitrophenyl α-D-glucopyranoside, α-D-glucopyranosyl, α-L-sorofuranoside, lactulosucrose, and sucrose. 10 . The method of claim 6 , wherein the acceptor comprising at least one hydroxyl moiety is selected from the group of polysaccharides comprising glucans, dextrans branched in α-1,2, alternans, mutans, reuterans, starch, amylopectin, amylose, glycogen, and pullulan. 11 . The method of claim 6 , wherein the acceptor connected to glucosyl units in alpha-1,3 is a bulking agent, a thickener, an emulsifier, a texturing agent and/or a stabilizer.
produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins · CPC title
Dextran; Derivatives thereof · CPC title
Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters · CPC title
Pullulan · CPC title
Hexosyltransferases (2.4.1) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.